Orphazyme A/S ADR (ORPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1999 | 12-1998 | 12-1993 | 12-1992 | 12-1991 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 160 | 110 | 0 | 0 | 0 |
| TOTAL | $160 | $110 | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 350 | 300 | N/A | N/A | N/A |
| Other Non-Current Assets | 40 | 0 | 0 | 0 | 0 |
| TOTAL | $390 | $300 | $N/A | $N/A | $N/A |
| Total Assets | $550 | $410 | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 560 | 580 | 61 | 61 | 0 |
| Accrued Expenses | 2,110 | 2,880 | 15 | 15 | N/A |
| TOTAL | $2,670 | $3,460 | $76 | $76 | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,670 | $3,460 | $76 | $76 | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 60 | 60 | 12 | 12 | N/A |
| Other shareholders' equity | -5 | -2 | 0 | 0 | 0 |
| TOTAL | $43,795 | $39,998 | $5,884 | $5,884 | $N/A |
| Total Liabilities And Equity | $46,465 | $43,458 | $5,960 | $5,960 | $0 |